SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-021234
Filing Date
2023-05-11
Accepted
2023-05-11 16:11:11
Documents
62
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rphm-20230331.htm   iXBRL 10-Q 2198972
2 EX-31.1 rphm-ex31_1.htm EX-31.1 21582
3 EX-31.2 rphm-ex31_2.htm EX-31.2 21230
4 EX-32.1 rphm-ex32_1.htm EX-32.1 19393
5 GRAPHIC img27525098_0.jpg GRAPHIC 11204
  Complete submission text file 0000950170-23-021234.txt   7044653

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rphm-20230331_cal.xml EX-101.CAL 34082
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rphm-20230331.xsd EX-101.SCH 42031
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rphm-20230331_def.xml EX-101.DEF 185437
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rphm-20230331_lab.xml EX-101.LAB 349846
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rphm-20230331_pre.xml EX-101.PRE 289429
56 EXTRACTED XBRL INSTANCE DOCUMENT rphm-20230331_htm.xml XML 1156817
Mailing Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612
Business Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612 (858) 283-0280
Reneo Pharmaceuticals, Inc. (Filer) CIK: 0001637715 (see all company filings)

IRS No.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40315 | Film No.: 23911110
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences